Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jean Bousquet and Claus Bachert.
Connection Strength

6.956
  1. Endotype-driven care pathways in patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2018 05; 141(5):1543-1551.
    View in: PubMed
    Score: 0.766
  2. Management of anaphylaxis due to COVID-19 vaccines in the elderly. Allergy. 2021 10; 76(10):2952-2964.
    View in: PubMed
    Score: 0.243
  3. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. Allergy. 2020 10; 75(10):2440-2444.
    View in: PubMed
    Score: 0.226
  4. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2021 03; 76(3):689-697.
    View in: PubMed
    Score: 0.226
  5. Sensitisation to staphylococcal enterotoxins and asthma severity: a longitudinal study in the EGEA cohort. Eur Respir J. 2019 09; 54(3).
    View in: PubMed
    Score: 0.210
  6. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care? J Allergy Clin Immunol Pract. 2019 Nov - Dec; 7(8):2511-2523.
    View in: PubMed
    Score: 0.210
  7. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). J Thorac Dis. 2019 Aug; 11(8):3633-3642.
    View in: PubMed
    Score: 0.209
  8. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019; 9:16.
    View in: PubMed
    Score: 0.203
  9. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS. Clin Exp Allergy. 2018 12; 48(12):1640-1653.
    View in: PubMed
    Score: 0.196
  10. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management. Clin Transl Allergy. 2018; 8:25.
    View in: PubMed
    Score: 0.193
  11. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study. Allergy. 2018 08; 73(8):1622-1631.
    View in: PubMed
    Score: 0.191
  12. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study. Allergy. 2018 09; 73(9):1763-1774.
    View in: PubMed
    Score: 0.190
  13. European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017). Clin Transl Allergy. 2017; 7:49.
    View in: PubMed
    Score: 0.187
  14. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report. Clin Transl Allergy. 2017; 7:37.
    View in: PubMed
    Score: 0.185
  15. Impact of Rhinitis on Work Productivity: A Systematic Review. J Allergy Clin Immunol Pract. 2018 Jul - Aug; 6(4):1274-1286.e9.
    View in: PubMed
    Score: 0.184
  16. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study. Allergy. 2018 02; 73(2):505-510.
    View in: PubMed
    Score: 0.184
  17. Sensitization patterns and minimum screening panels for aeroallergens in self-reported allergic rhinitis in China. Sci Rep. 2017 08 24; 7(1):9286.
    View in: PubMed
    Score: 0.183
  18. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project). Allergy. 2018 Jan; 73(1):77-92.
    View in: PubMed
    Score: 0.183
  19. [ARIA 2016 executive summary: Integrated care pathways for predictive medicine throughout the life cycle in Argentina]. Rev Alerg Mex. 2017 Jul-Sep; 64(3):298-308.
    View in: PubMed
    Score: 0.181
  20. Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy. 2017 Oct; 72(10):1475-1484.
    View in: PubMed
    Score: 0.180
  21. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy. 2017; 7:17.
    View in: PubMed
    Score: 0.180
  22. Staphylococcus aureus enterotoxin sensitization is associated with allergic poly-sensitization and allergic multimorbidity in adolescents. Allergy. 2017 Oct; 72(10):1548-1555.
    View in: PubMed
    Score: 0.179
  23. Google Trends terms reporting rhinitis and related topics differ in European countries. Allergy. 2017 Aug; 72(8):1261-1266.
    View in: PubMed
    Score: 0.177
  24. [ARIA 2016 executive summary: integrated care pathways for predictive medicine across the life cycle]. Tuberk Toraks. 2017 Mar; 65(1):32-40.
    View in: PubMed
    Score: 0.177
  25. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017 Jun; 72(6):857-865.
    View in: PubMed
    Score: 0.176
  26. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy. 2017; 7:5.
    View in: PubMed
    Score: 0.176
  27. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016; 6:47.
    View in: PubMed
    Score: 0.175
  28. Hypothesis: may e-cigarette smoking boost the allergic epidemic? Clin Transl Allergy. 2016; 6:40.
    View in: PubMed
    Score: 0.173
  29. Efficacy of desloratadine in persistent allergic rhinitis - a GA²LEN study. Int Arch Allergy Immunol. 2010; 153(4):395-402.
    View in: PubMed
    Score: 0.111
  30. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2 LEN consensus. Allergy. 2021 08; 76(8):2354-2366.
    View in: PubMed
    Score: 0.059
  31. Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper. Allergy. 2021 03; 76(3):677-688.
    View in: PubMed
    Score: 0.058
  32. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper. Allergy. 2021 03; 76(3):648-676.
    View in: PubMed
    Score: 0.058
  33. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020 07; 75(7):1546-1554.
    View in: PubMed
    Score: 0.056
  34. Patient Advisory Board for Chronic Rhinosinusitis - A EUFOREA initiative. Rhinology. 2019 Oct 01; 57(5):331-335.
    View in: PubMed
    Score: 0.053
  35. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. J Allergy Clin Immunol. 2019 07; 144(1):135-143.e6.
    View in: PubMed
    Score: 0.051
  36. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1418-1429.
    View in: PubMed
    Score: 0.051
  37. Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium: a BelSACI-Abeforcal-EUFOREA statement. Clin Transl Allergy. 2019; 9:1.
    View in: PubMed
    Score: 0.050
  38. Rhinology future trends: 2017 EUFOREA debate on allergic rhinitis. Rhinology. 2019 Feb 01; 57(1):49-56.
    View in: PubMed
    Score: 0.050
  39. mySinusitisCoach: patient empowerment in chronic rhinosinusitis using mobile technology. Rhinology. 2018 Sep 01; 56(3):209-215.
    View in: PubMed
    Score: 0.049
  40. Rhinology Future Debates 2017 by EUFOREA: Novel treatments and surgical solutions in rhinology. Clin Otolaryngol. 2018 12; 43(6):1429-1438.
    View in: PubMed
    Score: 0.049
  41. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study. World Allergy Organ J. 2018; 11(1):15.
    View in: PubMed
    Score: 0.049
  42. Rhinology Future Debates, an EUFOREA Report. Rhinology. 2017 Dec 01; 55(4):298-304.
    View in: PubMed
    Score: 0.047
  43. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. Rhinology. 2017 Sep 01; 55(3):202-210.
    View in: PubMed
    Score: 0.046
  44. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017 Oct; 140(4):950-958.
    View in: PubMed
    Score: 0.045
  45. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017 Nov; 72(11):1657-1665.
    View in: PubMed
    Score: 0.045
  46. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017 Sep; 72(9):1297-1305.
    View in: PubMed
    Score: 0.045
  47. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol. 2017 02; 139(2):388-399.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.